Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial


Creative Commons License

Solomon S. D. , Rizkala A. R. , Lefkowitz M. P. , Shi V. C. , Gong J., Anavekar N., ...Daha Fazla

CIRCULATION-HEART FAILURE, cilt.11, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

BACKGROUND: To describe the baseline characteristics of patients with heart failure and preserved left ventricular ejection fraction enrolled in the PARAGON-HF trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin Receptor Blocker Global Outcomes in HFpEF) comparing sacubitril/valsartan to valsartan in reducing morbidity and mortality.